glucose, (beta-d)-isomer has been researched along with acetylcysteine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Hedenborg, M; Klockars, M | 1 |
| Kharazmi, A; Nielsen, H; Schiøtz, PO | 1 |
| Huupponen, MR; Hyvönen, PM; Mäkinen, LH; Rankinen, T; Rauramaa, R; Sen, CK; Väisänen, S | 1 |
| Andersson, R; Deng, X; Lasson, A; Sun, Z; Wang, X | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Mazzon, E | 1 |
| Beyreuther, K; Picard, MA; Uhrig, RK; Wiessler, M | 1 |
| Akhand, AA; Dai, Y; Du, J; Hayakawa, A; Hossain, K; Nakashima, I; Rifa'i, M; Suzuki, H; Takeda, K; Tsuboi, H | 1 |
| Hou, L; Ji, G; Li, N; Li, S; Lu, Y; Ma, S; Peng, D; Qin, M; Shang, L; Xie, K; Xiong, L | 1 |
| Gao, L; Guo, NN; Kang, JR; Li, F; Lu, JY; Sun, JZ; Wang, HW; Yang, W; Zhang, W | 1 |
| Gao, YW; Tang, L; Wang, ZC; Wei, RB; Xing, Y; Yang, Y; Zheng, XY | 1 |
| Awasthi, S; Horne, D; Jain, D; Singhal, J; Singhal, P; Singhal, SS | 1 |
| Li, F; Li, W; Song, D; Zhu, Y | 1 |
| Accinni, R; Beretta, A; Biswas, P; Dellanoce, C; Malnati, M; Mrakic-Sposta, S; Vezzoli, A | 1 |
| Fang, Y; Gong, W; Liu, M; Liu, S; Liu, Y; Qin, L; Yu, Y; Zhang, Q; Zhao, L; Zhu, L | 1 |
| Abo-Youssef, AM; Hassan, MIA; Hemeida, RAM; Osman, AT; Sharkawi, SMZ | 1 |
1 review(s) available for glucose, (beta-d)-isomer and acetylcysteine
| Article | Year |
|---|---|
Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apigenin; Docetaxel; Drug Resistance, Neoplasm; Glucosides; Humans; Male; Prostatic Neoplasms; Signal Transduction; Taxoids | 2017 |
1 trial(s) available for glucose, (beta-d)-isomer and acetylcysteine
| Article | Year |
|---|---|
Antioxidant Activity with Increased Endogenous Levels of Vitamin C, E and A Following Dietary Supplementation with a Combination of Glutathione and Resveratrol Precursors.
Topics: Acetylcysteine; Aged; Alanine; Antioxidants; Ascorbic Acid; Dietary Supplements; Erythrocytes; Female; Glucosides; Glutamine; Glutathione; Glycine; Humans; Ketoglutaric Acids; Male; Middle Aged; Neopterin; Oxidation-Reduction; Resveratrol; Stilbenes; Sulfhydryl Compounds; Vitamin A; Vitamin E; Vitamins | 2020 |
14 other study(ies) available for glucose, (beta-d)-isomer and acetylcysteine
| Article | Year |
|---|---|
Quartz-dust-induced production of reactive oxygen metabolites by human granulocytes.
Topics: Acetylcysteine; Humans; Hydrogen Peroxide; Luminescent Measurements; Neutrophils; Nitroblue Tetrazolium; Oxygen Consumption; Polyvinylpyridine N-Oxide; Quartz; Silicon Dioxide; Superoxides; Zymosan | 1989 |
N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism.
Topics: Acetylcysteine; Catalase; Cell Survival; Chemotaxis, Leukocyte; Humans; In Vitro Techniques; Luminescent Measurements; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Superoxide Dismutase; Zymosan | 1988 |
The effect of N-acetylcysteine on exercise-induced priming of human neutrophils. A chemiluminescence study.
Topics: Acetylcysteine; Adult; Blood; Exercise Test; Free Radical Scavengers; Humans; Indicators and Reagents; Luminescent Measurements; Luminol; Male; Neutrophil Activation; Neutrophils; Physical Exertion; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Zymosan | 1995 |
Alterations in the functions of the reticuloendothelial and protease-antiprotease systems after intraperitoneal injection of zymosan in rats.
Topics: Acetylcysteine; Animals; Antioxidants; Dimethyl Sulfoxide; Endopeptidases; Escherichia coli; Injections, Intraperitoneal; Iodine Radioisotopes; Male; Mononuclear Phagocyte System; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Time Factors; Zymosan | 1998 |
Protective effect of N-acetylcysteine on cellular energy depletion in a non-septic shock model induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Cell Membrane Permeability; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Energy Metabolism; Free Radical Scavengers; Macrophages, Peritoneal; Male; NAD; Nitrates; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sepsis; Shock; Tyrosine; Zymosan | 1999 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Leukocyte Count; Male; Multiple Organ Failure; Nitrates; Nitric Oxide; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Analysis; Time Factors; Zymosan | 1999 |
Synthesis of antioxidative and anti-inflammatory drugs glucoconjugates.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Biological Availability; Gallic Acid; Gentisates; Glucosides; Glycoconjugates; Hydroxybenzoates; Ibuprofen; Magnetic Resonance Spectroscopy; Phenols; Sulfhydryl Compounds; Vitamin E | 2000 |
Paeoniflorin induces apoptosis of lymphocytes through a redox-linked mechanism.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Benzoates; Bridged-Ring Compounds; Caspases; Curcumin; Dithiothreitol; Enzyme Activation; Enzyme Inhibitors; Glucosides; Humans; Jurkat Cells; Lymphocytes; Membrane Potentials; Mice; Mitochondria; Mitogen-Activated Protein Kinases; Monoterpenes; Oxidation-Reduction; Paeonia; Phosphorylation; Reactive Oxygen Species | 2004 |
Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Cytokines; Free Radical Scavengers; Heart; Inflammation; Kidney; Liver; Lung; Male; Mice; Multiple Organ Failure; Myocardium; Oxygen; Reactive Oxygen Species; Sepsis; Thiourea; Zymosan | 2010 |
N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model.
Topics: Acetylcysteine; Animals; Apoptosis; Cytokines; Dendritic Cells; Disease Models, Animal; Enzyme Activation; Histocompatibility Antigens Class II; Inflammation; Lung; Male; Mice; NF-kappa B; Receptors, CCR5; Receptors, CCR7; Respiratory Function Tests; RNA, Messenger; Zymosan | 2013 |
Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism.
Topics: Acetylcysteine; Animals; Contrast Media; Cytoprotection; Glucosides; Kidney; Kidney Diseases; Oxidative Stress; Phenols; Rats; Rats, Wistar; Signal Transduction | 2015 |
RETRACTED: Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2.
Topics: Acetylcysteine; Adenylate Kinase; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Emodin; Glioblastoma; Glucosides; Humans; Reactive Oxygen Species; S-Phase Kinase-Associated Proteins; TOR Serine-Threonine Kinases | 2017 |
Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
Topics: Acetylcysteine; Actins; Animals; Benzoates; Bone Resorption; Cell Differentiation; Cell Survival; Drug Synergism; Glucosides; Hydrogen Peroxide; Kelch-Like ECH-Associated Protein 1; Mice; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NF-E2-Related Factor 2; NF-kappa B; Osteoblasts; Osteoclasts; Osteogenesis; Oxidative Stress; RANK Ligand; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction; Tartrate-Resistant Acid Phosphatase | 2021 |
Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats.
Topics: Acetylcysteine; Animals; Benzhydryl Compounds; Glucosides; Hesperidin; Inflammation; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Protective Agents; Rats; Signal Transduction | 2021 |